Virtual Reality Therapy for Cancer-Treatment Associated Symptoms
Implementation of an At-Home Multimodal Integrative Therapy Via Virtual Reality for Patients With Cancer-Treatment Associated Symptoms
University of Maryland, Baltimore
30 participants
Dec 4, 2024
INTERVENTIONAL
Conditions
Summary
We propose an innovative approach to symptom management in cancer patients following cancer treatments, utilizing a Multimodal Integrative Therapy (MIT) delivered via Virtual Reality (VR) program, authorized by the US Food and Drug Administration for in-home use. Our primary goal is to generate pilot data on the effects of MIT-VR program on pain, fatigue, sleep, depression, and anxiety in participants suffering from chronic cancer symptoms following cancer treatments.
Eligibility
Inclusion Criteria6
- Adults ages 18-88
- Cancer diagnosis (histology verified)
- Had surgical intervention, completed chemotherapy or radiation for therapeutic purposes
- >3 months since last cancer treatment, but participants currently undergoing endocrine or immunotherapy treatments are permissible
- Documented symptoms of cancer or cancer therapy including at least one of the following: pain, anxiety, sleep difficulty, fatigue, neuropathy
- English speaker (written and spoken)
Exclusion Criteria10
- Severe psychiatric condition (e.g. schizophrenia, bipolar disorders, autism) leading to hospitalization within the last 3 years
- Any personal (or family first degree) history of mania, schizophrenia, or other psychoses
- Diagnosis and treatment of chronic pain, neuropathy, fatigue, sleep or anxiety disorder prior to cancer diagnosis
- Current Hospice or palliative care only recipients
- Color-blindness
- Impaired or uncorrected hearing
- Lifetime alcohol/drug dependence or alcohol/drug abuse in past 3 months
- Conditions that would interfere with the VR mask placement (e.g. trauma, burn, infection)
- Known history of severe motion sickness
- Pregnancy or breast feeding
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The RelieVRx program is a prescription-use immersive virtual reality system intended to provide adjunctive treatment based on cognitive behavioral therapy skills and other evidence-based behavioral methods for patients (age 18 and older) with a diagnosis of chronic lower back pain (defined as moderate to severe pain lasting longer than three months). The device is intended for in-home use for the reduction of pain and pain interference associated with chronic lower back pain.
Audio Mp4 modules ranging from 3-15 minutes with guided meditation.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06248216